A definite measure of occupancy exposures, seeking with non-radiolabeled in vivo 5-HT2A receptor occupancy and in vitro free fractions

References

• Friden M, Gupta A, Antonsson M, et al. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids. Drug Metab Dispos. 2007;35:1711–1719.
   PubMed Web of Science ®Google Scholar
• Watson J, Wright S, Lucas A, et al. Receptor occupancy and brain free fraction. Drug Metab Dispos. 2009;37:753–760.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen C, Smith BJ. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther. 2008;325:349–356.
   PubMed Web of Science ®Google Scholar
• Summerfield SG, Stevens AJ, Cutler L, et al. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther. 2005;316:1282–1290.
   PubMed Web of Science ®Google Scholar
• Liu X, Vilenski O, Kwan J, et al. Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats. Drug Metab Dispos. 2009;37:1548–1556.
   PubMed Web of Science ®Google Scholar
• Barth VN, Chernet E, Martin LJ, et al. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer. Life Sci. 2006;78:3007–3012.
   PubMed Web of Science ®Google Scholar
• Ito H, Nyberg S, Halldin C, et al. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. J Nucl Med. 1998;39:208–214.
   PubMed Web of Science ®Google Scholar
• Chernet E, Martin LJ, Li D, et al. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples. Life Sci. 2005;78:340–346.
   PubMed Web of Science ®Google Scholar
• Thentu JB, Nirogi R, Bhyrapuneni G, et al. Simultaneous in-vivo receptor occupancy assays for serotonin 1A, 2A, and dopamine 2 receptors with the use of non-radiolabelled tracers: proposed method in screening antipsychotics. J Pharmacol Toxicol Methods. 2017;85:22–28.
   PubMed Web of Science ®Google Scholar
• Celada P, Puig M, Amargós-Bosch M, et al. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci. 2004;29:252–265.
   PubMed Web of Science ®Google Scholar
• Ichikawa J, Ishii H, Bonaccorso S, et al. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem. 2001;76:1521–1531.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Describing an atypical antipsychotic: receptor binding and its role in pathophysiology. Primary Care Companion J Clin Psychiatry. 2003;5:9–13.
   Google Scholar
• Chemicalize [Internet]. Budapest, Hungary: ChemAxon; [cited 2017 Mar 01]. Available from: https://chemicalize.com/#/calculation
   Google Scholar
• Bymaster FP, Calligaro DO, Falcone JF, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996;14:87–96.
   PubMed Web of Science ®Google Scholar
• Rinaldi-Carmona M, Congy C, Santucci V, et al. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. J Pharmacol Exp Ther. 1992;262:759–768.
   PubMed Web of Science ®Google Scholar
• Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl). 1996;124:57–73.
   PubMed Web of Science ®Google Scholar
• Comparison of in vivo receptor occupancy studies using a radioligand-based approach or a liquid chromatography/mass spectrometry-based approach [Internet]. Worcester (MA): Biomedical Research Models Inc. [cited 2016 Jun 23]. Available from: https://biomere.com/wp-content/uploads/2016/06/rat_ReceptorOccupancyposter.pdf
   Google Scholar
• Tauscher J, Jones C, Remington G, et al. Significant dissociation of brain and plasma kinetics with antipsychotics. Mol Psychiatry. 2002;7:317–321.
   PubMed Web of Science ®Google Scholar
• Tillement JP, Urien S, Chaumet-Riffaud P, et al. Blood binding and tissue uptake of drugs. Recent advances and perspectives. Fundam Clin Pharmacol. 1988;2:223–238.
   PubMed Web of Science ®Google Scholar
• de Lange EC, Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet. 2002;41:691–703.
   PubMed Web of Science ®Google Scholar
• Kaufmann AM, Krise JP. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci. 2007;96:729–746.
   PubMed Web of Science ®Google Scholar
• Bundgaard C, Sveigaard C, Brennum LT, et al. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations. Xenobiotica. 2012;42:256–265.
   PubMed Web of Science ®Google Scholar
• Johnson MP, Siegel BW, Carr AA. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:205–209.
   PubMed Web of Science ®Google Scholar
• Summerfield SG, Read K, Begley DJ, et al. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther. 2007;322:205–213.
   PubMed Web of Science ®Google Scholar
• Jeffrey P, Summerfield SG. Challenges for blood-brain barrier (BBB) screening. Xenobiotica. 2007;37:1135–1151.
   PubMed Web of Science ®Google Scholar
• Cserr HF, Bundgaard M. Blood-brain interfaces in vertebrates: a comparative approach. Am J Physiol. 1984;246:R277–R288.
   PubMed Web of Science ®Google Scholar
• Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol. 1984;247:H484–H493.
   PubMed Web of Science ®Google Scholar